speb/financial-data huggingface dataset:
DIVISLAB.NS income_statement (annual, 2025-03-31) — +Operating Expense: 28840000000.00
DIVISLAB.NS income_statement (quarterly, 2025-03-31) — +Operating Expense: 8250000000.00
DIVISLAB.NS income_statement (annual, 2025-03-31) — +Total Revenue: 93250000000.00
DIVISLAB.NS income_statement (quarterly, 2025-03-31) — +Total Revenue: 25850000000.00
DIVISLAB.NS balance_sheet (annual, 2025-03-31) — Accounts Payable: 9100000000.00
DIVISLAB.NS balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 9100000000.00
DIVISLAB.NS balance_sheet (annual, 2025-03-31) — Accounts Receivable: 27310000000.00
DIVISLAB.NS balance_sheet (quarterly, 2025-03-31) — Accounts Receivable: 27310000000.00
DIVISLAB.NS balance_sheet (annual, 2025-03-31) — Accumulated Depreciation: -23980000000.00
DIVISLAB.NS balance_sheet (quarterly, 2025-03-31) — Accumulated Depreciation: -23980000000.00
DIVISLAB.NS balance_sheet (annual, 2025-03-31) — Additional Paid In Capital: 800000000.00
DIVISLAB.NS balance_sheet (quarterly, 2025-03-31) — Additional Paid In Capital: 800000000.00
DIVISLAB.NS balance_sheet (annual, 2025-03-31) — Allowance For Doubtful Accounts Receivable: -70000000.00
DIVISLAB.NS balance_sheet (quarterly, 2025-03-31) — Allowance For Doubtful Accounts Receivable: -70000000.00
DIVISLAB.NS income_statement (annual, 2025-03-31) — Amortization: 30000000.00
DIVISLAB.NS cash_flow (annual, 2025-03-31) — Amortization Cash Flow: 30000000.00
DIVISLAB.NS balance_sheet (annual, 2025-03-31) — Available For Sale Securities: 1270000000.00
DIVISLAB.NS balance_sheet (quarterly, 2025-03-31) — Available For Sale Securities: 1270000000.00
DIVISLAB.NS income_statement (annual, 2025-03-31) — Basic Average Shares: 265468580.00
DIVISLAB.NS income_statement (quarterly, 2025-03-31) — Basic Average Shares: 265543522.00
DIVISLAB.NS income_statement (annual, 2025-03-31) — Basic EPS: 82.53
DIVISLAB.NS income_statement (quarterly, 2025-03-31) — Basic EPS: 24.93
DIVISLAB.NS cash_flow (annual, 2025-03-31) — Beginning Cash Position: 3630000000.00
DIVISLAB.NS balance_sheet (annual, 2025-03-31) — Buildings And Improvements: 60000000.00
DIVISLAB.NS balance_sheet (quarterly, 2025-03-31) — Buildings And Improvements: 60000000.00
DIVISLAB.NS cash_flow (annual, 2025-03-31) — Capital Expenditure: -14380000000.00
DIVISLAB.NS balance_sheet (annual, 2025-03-31) — Capital Lease Obligations: 20000000.00
DIVISLAB.NS balance_sheet (quarterly, 2025-03-31) — Capital Lease Obligations: 20000000.00
DIVISLAB.NS balance_sheet (annual, 2025-03-31) — Capital Stock: 530000000.00
DIVISLAB.NS balance_sheet (quarterly, 2025-03-31) — Capital Stock: 530000000.00
DIVISLAB.NS balance_sheet (annual, 2025-03-31) — Cash And Cash Equivalents: 4150000000.00
DIVISLAB.NS balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 4150000000.00
DIVISLAB.NS balance_sheet (annual, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 35390000000.00
DIVISLAB.NS balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 35390000000.00
DIVISLAB.NS cash_flow (annual, 2025-03-31) — Cash Dividends Paid: -7960000000.00
DIVISLAB.NS balance_sheet (annual, 2025-03-31) — Cash Equivalents: 3940000000.00
DIVISLAB.NS balance_sheet (quarterly, 2025-03-31) — Cash Equivalents: 3940000000.00
DIVISLAB.NS balance_sheet (annual, 2025-03-31) — Cash Financial: 210000000.00
DIVISLAB.NS balance_sheet (quarterly, 2025-03-31) — Cash Financial: 210000000.00
DIVISLAB.NS cash_flow (annual, 2025-03-31) — Change In Inventory: -520000000.00
DIVISLAB.NS cash_flow (annual, 2025-03-31) — Change In Other Current Assets: -650000000.00
DIVISLAB.NS cash_flow (annual, 2025-03-31) — Change In Other Current Liabilities: 430000000.00
DIVISLAB.NS cash_flow (annual, 2025-03-31) — Change In Payable: 950000000.00
DIVISLAB.NS cash_flow (annual, 2025-03-31) — Change In Receivables: -5820000000.00
DIVISLAB.NS cash_flow (annual, 2025-03-31) — Change In Working Capital: -5540000000.00
DIVISLAB.NS cash_flow (annual, 2025-03-31) — Changes In Cash: 500000000.00
DIVISLAB.NS balance_sheet (annual, 2025-03-31) — Common Stock: 530000000.00
DIVISLAB.NS balance_sheet (quarterly, 2025-03-31) — Common Stock: 530000000.00
DIVISLAB.NS balance_sheet (annual, 2025-03-31) — Common Stock Equity: 149690000000.00
DIVISLAB.NS balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 149690000000.00
DIVISLAB.NS balance_sheet (annual, 2025-03-31) — Construction In Progress: 12600000000.00
DIVISLAB.NS balance_sheet (quarterly, 2025-03-31) — Construction In Progress: 12600000000.00
DIVISLAB.NS income_statement (annual, 2025-03-31) — Cost Of Revenue: 38700000000.00
DIVISLAB.NS income_statement (quarterly, 2025-03-31) — Cost Of Revenue: 9810000000.00
DIVISLAB.NS balance_sheet (annual, 2025-03-31) — Current Assets: 100810000000.00
DIVISLAB.NS balance_sheet (quarterly, 2025-03-31) — Current Assets: 100810000000.00
DIVISLAB.NS balance_sheet (annual, 2025-03-31) — Current Capital Lease Obligation: 0.00
DIVISLAB.NS balance_sheet (quarterly, 2025-03-31) — Current Capital Lease Obligation: 0.00
DIVISLAB.NS balance_sheet (annual, 2025-03-31) — Current Debt: 20000000.00
DIVISLAB.NS balance_sheet (quarterly, 2025-03-31) — Current Debt: 20000000.00
DIVISLAB.NS balance_sheet (annual, 2025-03-31) — Current Debt And Capital Lease Obligation: 20000000.00
DIVISLAB.NS balance_sheet (quarterly, 2025-03-31) — Current Debt And Capital Lease Obligation: 20000000.00
DIVISLAB.NS balance_sheet (annual, 2025-03-31) — Current Liabilities: 14520000000.00
DIVISLAB.NS balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 14520000000.00
DIVISLAB.NS balance_sheet (annual, 2025-03-31) — Current Provisions: 540000000.00
DIVISLAB.NS balance_sheet (quarterly, 2025-03-31) — Current Provisions: 540000000.00
DIVISLAB.NS cash_flow (annual, 2025-03-31) — Depreciation: 3990000000.00
DIVISLAB.NS cash_flow (annual, 2025-03-31) — Depreciation And Amortization: 4020000000.00
DIVISLAB.NS income_statement (annual, 2025-03-31) — Depreciation And Amortization In Income Statement: 4020000000.00
DIVISLAB.NS income_statement (quarterly, 2025-03-31) — Depreciation And Amortization In Income Statement: 1070000000.00
DIVISLAB.NS income_statement (annual, 2025-03-31) — Depreciation Income Statement: 3990000000.00
DIVISLAB.NS income_statement (quarterly, 2025-03-31) — Depreciation Income Statement: 1070000000.00
DIVISLAB.NS income_statement (annual, 2025-03-31) — Diluted Average Shares: 265468580.00
DIVISLAB.NS income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 265543522.00
DIVISLAB.NS income_statement (annual, 2025-03-31) — Diluted EPS: 82.53
DIVISLAB.NS income_statement (quarterly, 2025-03-31) — Diluted EPS: 24.93
DIVISLAB.NS income_statement (annual, 2025-03-31) — Diluted NI Availto Com Stockholders: 21910000000.00
DIVISLAB.NS income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: 6620000000.00
DIVISLAB.NS balance_sheet (annual, 2025-03-31) — Dividends Payable: 10000000.00
DIVISLAB.NS balance_sheet (quarterly, 2025-03-31) — Dividends Payable: 10000000.00
DIVISLAB.NS income_statement (annual, 2025-03-31) — EBIT: 29180000000.00
DIVISLAB.NS income_statement (quarterly, 2025-03-31) — EBIT: 8650000000.00
DIVISLAB.NS income_statement (annual, 2025-03-31) — EBITDA: 33200000000.00
DIVISLAB.NS income_statement (quarterly, 2025-03-31) — EBITDA: 9720000000.00
DIVISLAB.NS cash_flow (annual, 2025-03-31) — End Cash Position: 4130000000.00
DIVISLAB.NS balance_sheet (annual, 2025-03-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 650000000.00
DIVISLAB.NS balance_sheet (quarterly, 2025-03-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 650000000.00
DIVISLAB.NS cash_flow (annual, 2025-03-31) — Financing Cash Flow: -7990000000.00
DIVISLAB.NS balance_sheet (annual, 2025-03-31) — Finished Goods: 3350000000.00
DIVISLAB.NS balance_sheet (quarterly, 2025-03-31) — Finished Goods: 3350000000.00
DIVISLAB.NS cash_flow (annual, 2025-03-31) — Free Cash Flow: 2150000000.00
DIVISLAB.NS cash_flow (annual, 2025-03-31) — Gain Loss On Investment Securities: -50000000.00
DIVISLAB.NS cash_flow (annual, 2025-03-31) — Gain Loss On Sale Of PPE: 40000000.00
DIVISLAB.NS income_statement (annual, 2025-03-31) — General And Administrative Expense: 1430000000.00
DIVISLAB.NS balance_sheet (annual, 2025-03-31) — Goodwill And Other Intangible Assets: 40000000.00
DIVISLAB.NS balance_sheet (quarterly, 2025-03-31) — Goodwill And Other Intangible Assets: 40000000.00
DIVISLAB.NS balance_sheet (annual, 2025-03-31) — Gross Accounts Receivable: 27380000000.00
DIVISLAB.NS balance_sheet (quarterly, 2025-03-31) — Gross Accounts Receivable: 27380000000.00
DIVISLAB.NS balance_sheet (annual, 2025-03-31) — Gross PPE: 90960000000.00
DIVISLAB.NS balance_sheet (quarterly, 2025-03-31) — Gross PPE: 90960000000.00
DIVISLAB.NS income_statement (annual, 2025-03-31) — Gross Profit: 54550000000.00
DIVISLAB.NS income_statement (quarterly, 2025-03-31) — Gross Profit: 16040000000.00
DIVISLAB.NS balance_sheet (annual, 2025-03-31) — Hedging Assets Current: 0.00
DIVISLAB.NS balance_sheet (quarterly, 2025-03-31) — Hedging Assets Current: 0.00
DIVISLAB.NS income_statement (annual, 2025-03-31) — Interest Expense: 20000000.00
DIVISLAB.NS income_statement (quarterly, 2025-03-31) — Interest Expense: 10000000.00
DIVISLAB.NS income_statement (annual, 2025-03-31) — Interest Expense Non Operating: 20000000.00
DIVISLAB.NS income_statement (quarterly, 2025-03-31) — Interest Expense Non Operating: 10000000.00
DIVISLAB.NS income_statement (annual, 2025-03-31) — Interest Income: 2950000000.00
DIVISLAB.NS income_statement (annual, 2025-03-31) — Interest Income Non Operating: 2950000000.00
DIVISLAB.NS cash_flow (annual, 2025-03-31) — Interest Paid Cff: -20000000.00
DIVISLAB.NS cash_flow (annual, 2025-03-31) — Interest Received Cfi: 2950000000.00
DIVISLAB.NS balance_sheet (annual, 2025-03-31) — Inventory: 32360000000.00
DIVISLAB.NS balance_sheet (quarterly, 2025-03-31) — Inventory: 32360000000.00
DIVISLAB.NS balance_sheet (annual, 2025-03-31) — Invested Capital: 149710000000.00
DIVISLAB.NS balance_sheet (quarterly, 2025-03-31) — Invested Capital: 149710000000.00
DIVISLAB.NS cash_flow (annual, 2025-03-31) — Investing Cash Flow: -8040000000.00
DIVISLAB.NS balance_sheet (annual, 2025-03-31) — Investmentin Financial Assets: 650000000.00
DIVISLAB.NS balance_sheet (quarterly, 2025-03-31) — Investmentin Financial Assets: 650000000.00
DIVISLAB.NS balance_sheet (annual, 2025-03-31) — Land And Improvements: 23300000000.00
DIVISLAB.NS balance_sheet (quarterly, 2025-03-31) — Land And Improvements: 23300000000.00
DIVISLAB.NS balance_sheet (annual, 2025-03-31) — Long Term Capital Lease Obligation: 20000000.00
DIVISLAB.NS balance_sheet (quarterly, 2025-03-31) — Long Term Capital Lease Obligation: 20000000.00
DIVISLAB.NS balance_sheet (annual, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 20000000.00
DIVISLAB.NS balance_sheet (quarterly, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 20000000.00
DIVISLAB.NS balance_sheet (annual, 2025-03-31) — Machinery Furniture Equipment: 51870000000.00
DIVISLAB.NS balance_sheet (quarterly, 2025-03-31) — Machinery Furniture Equipment: 51870000000.00
DIVISLAB.NS income_statement (annual, 2025-03-31) — Minority Interests: 0.00
DIVISLAB.NS income_statement (quarterly, 2025-03-31) — Minority Interests: 0.00
DIVISLAB.NS cash_flow (annual, 2025-03-31) — Net Foreign Currency Exchange Gain Loss: 90000000.00
DIVISLAB.NS income_statement (annual, 2025-03-31) — Net Income: 21910000000.00
DIVISLAB.NS income_statement (quarterly, 2025-03-31) — Net Income: 6620000000.00
DIVISLAB.NS income_statement (annual, 2025-03-31) — Net Income Common Stockholders: 21910000000.00
DIVISLAB.NS income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: 6620000000.00
DIVISLAB.NS income_statement (annual, 2025-03-31) — Net Income Continuous Operations: 21910000000.00
DIVISLAB.NS income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: 6620000000.00
DIVISLAB.NS income_statement (annual, 2025-03-31) — Net Income From Continuing And Discontinued Operation: 21910000000.00
DIVISLAB.NS income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: 6620000000.00
DIVISLAB.NS income_statement (annual, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: 21910000000.00
DIVISLAB.NS income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: 6620000000.00
DIVISLAB.NS cash_flow (annual, 2025-03-31) — Net Income From Continuing Operations: 29160000000.00
DIVISLAB.NS income_statement (annual, 2025-03-31) — Net Income Including Noncontrolling Interests: 21910000000.00
DIVISLAB.NS income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: 6620000000.00
DIVISLAB.NS income_statement (annual, 2025-03-31) — Net Interest Income: 2920000000.00
DIVISLAB.NS income_statement (quarterly, 2025-03-31) — Net Interest Income: -10000000.00
DIVISLAB.NS cash_flow (annual, 2025-03-31) — Net Investment Purchase And Sale: 3390000000.00
DIVISLAB.NS income_statement (annual, 2025-03-31) — Net Non Operating Interest Income Expense: 2920000000.00
DIVISLAB.NS income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: -10000000.00
DIVISLAB.NS balance_sheet (annual, 2025-03-31) — Net PPE: 66980000000.00
DIVISLAB.NS balance_sheet (quarterly, 2025-03-31) — Net PPE: 66980000000.00
DIVISLAB.NS cash_flow (annual, 2025-03-31) — Net PPE Purchase And Sale: -14380000000.00
DIVISLAB.NS balance_sheet (annual, 2025-03-31) — Net Tangible Assets: 149650000000.00
DIVISLAB.NS balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: 149650000000.00
DIVISLAB.NS balance_sheet (annual, 2025-03-31) — Non Current Deferred Revenue: 0.00
DIVISLAB.NS balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Revenue: 0.00
DIVISLAB.NS balance_sheet (annual, 2025-03-31) — Non Current Deferred Taxes Assets: 110000000.00
DIVISLAB.NS balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Taxes Assets: 110000000.00
DIVISLAB.NS balance_sheet (annual, 2025-03-31) — Non Current Deferred Taxes Liabilities: 5090000000.00
DIVISLAB.NS balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Taxes Liabilities: 5090000000.00
DIVISLAB.NS balance_sheet (annual, 2025-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 0.00
DIVISLAB.NS balance_sheet (quarterly, 2025-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 0.00
DIVISLAB.NS balance_sheet (annual, 2025-03-31) — Non Current Prepaid Assets: 720000000.00
DIVISLAB.NS balance_sheet (quarterly, 2025-03-31) — Non Current Prepaid Assets: 720000000.00
DIVISLAB.NS income_statement (annual, 2025-03-31) — Normalized EBITDA: 33190000000.00
DIVISLAB.NS income_statement (quarterly, 2025-03-31) — Normalized EBITDA: 9720000000.00
DIVISLAB.NS income_statement (annual, 2025-03-31) — Normalized Income: 21902486282.58
DIVISLAB.NS income_statement (quarterly, 2025-03-31) — Normalized Income: 6620000000.00
DIVISLAB.NS cash_flow (annual, 2025-03-31) — Operating Cash Flow: 16530000000.00
DIVISLAB.NS income_statement (annual, 2025-03-31) — Operating Income: 25710000000.00
DIVISLAB.NS income_statement (quarterly, 2025-03-31) — Operating Income: 7790000000.00
DIVISLAB.NS income_statement (annual, 2025-03-31) — Operating Revenue: 93250000000.00
DIVISLAB.NS income_statement (quarterly, 2025-03-31) — Operating Revenue: 25850000000.00
DIVISLAB.NS balance_sheet (annual, 2025-03-31) — Ordinary Shares Number: 265468580.00
DIVISLAB.NS balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 265468580.00
DIVISLAB.NS balance_sheet (annual, 2025-03-31) — Other Current Assets: 10000000.00
DIVISLAB.NS balance_sheet (quarterly, 2025-03-31) — Other Current Assets: 10000000.00
DIVISLAB.NS balance_sheet (annual, 2025-03-31) — Other Current Liabilities: 190000000.00
DIVISLAB.NS balance_sheet (quarterly, 2025-03-31) — Other Current Liabilities: 190000000.00
DIVISLAB.NS balance_sheet (annual, 2025-03-31) — Other Equity Interest: 149160000000.00
DIVISLAB.NS balance_sheet (quarterly, 2025-03-31) — Other Equity Interest: 149160000000.00
DIVISLAB.NS balance_sheet (annual, 2025-03-31) — Other Intangible Assets: 40000000.00
DIVISLAB.NS balance_sheet (quarterly, 2025-03-31) — Other Intangible Assets: 40000000.00
DIVISLAB.NS balance_sheet (annual, 2025-03-31) — Other Inventories: 90000000.00
DIVISLAB.NS balance_sheet (quarterly, 2025-03-31) — Other Inventories: 90000000.00
DIVISLAB.NS cash_flow (annual, 2025-03-31) — Other Non Cash Items: -2930000000.00
DIVISLAB.NS balance_sheet (annual, 2025-03-31) — Other Non Current Assets: 2480000000.00
DIVISLAB.NS balance_sheet (quarterly, 2025-03-31) — Other Non Current Assets: 2480000000.00
DIVISLAB.NS income_statement (annual, 2025-03-31) — Other Non Operating Income Expenses: 40000000.00
DIVISLAB.NS income_statement (quarterly, 2025-03-31) — Other Non Operating Income Expenses: 760000000.00
DIVISLAB.NS income_statement (annual, 2025-03-31) — Other Operating Expenses: 9510000000.00
DIVISLAB.NS income_statement (quarterly, 2025-03-31) — Other Operating Expenses: 3680000000.00
DIVISLAB.NS balance_sheet (annual, 2025-03-31) — Other Payable: 4250000000.00
DIVISLAB.NS balance_sheet (quarterly, 2025-03-31) — Other Payable: 4250000000.00
DIVISLAB.NS balance_sheet (annual, 2025-03-31) — Other Properties: 3190000000.00
DIVISLAB.NS balance_sheet (quarterly, 2025-03-31) — Other Properties: 3190000000.00
DIVISLAB.NS balance_sheet (annual, 2025-03-31) — Other Receivables: 10000000.00
DIVISLAB.NS balance_sheet (quarterly, 2025-03-31) — Other Receivables: 10000000.00
DIVISLAB.NS balance_sheet (annual, 2025-03-31) — Other Short Term Investments: 31240000000.00
DIVISLAB.NS balance_sheet (quarterly, 2025-03-31) — Other Short Term Investments: 31240000000.00
DIVISLAB.NS income_statement (annual, 2025-03-31) — Other Special Charges: 40000000.00
DIVISLAB.NS income_statement (annual, 2025-03-31) — Otherunder Preferred Stock Dividend: 0.00
DIVISLAB.NS income_statement (quarterly, 2025-03-31) — Otherunder Preferred Stock Dividend: 0.00
DIVISLAB.NS balance_sheet (annual, 2025-03-31) — Payables: 13360000000.00
DIVISLAB.NS balance_sheet (quarterly, 2025-03-31) — Payables: 13360000000.00
DIVISLAB.NS balance_sheet (annual, 2025-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 540000000.00
DIVISLAB.NS balance_sheet (quarterly, 2025-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 540000000.00
DIVISLAB.NS balance_sheet (annual, 2025-03-31) — Prepaid Assets: 1400000000.00
DIVISLAB.NS balance_sheet (quarterly, 2025-03-31) — Prepaid Assets: 1400000000.00
DIVISLAB.NS income_statement (annual, 2025-03-31) — Pretax Income: 29160000000.00
DIVISLAB.NS income_statement (quarterly, 2025-03-31) — Pretax Income: 8640000000.00
DIVISLAB.NS balance_sheet (annual, 2025-03-31) — Properties: 0.00
DIVISLAB.NS balance_sheet (quarterly, 2025-03-31) — Properties: 0.00
DIVISLAB.NS cash_flow (annual, 2025-03-31) — Provisionand Write Offof Assets: -20000000.00
DIVISLAB.NS cash_flow (annual, 2025-03-31) — Purchase Of Investment: -32240000000.00
DIVISLAB.NS cash_flow (annual, 2025-03-31) — Purchase Of PPE: -14380000000.00
DIVISLAB.NS balance_sheet (annual, 2025-03-31) — Raw Materials: 11940000000.00
DIVISLAB.NS balance_sheet (quarterly, 2025-03-31) — Raw Materials: 11940000000.00
DIVISLAB.NS income_statement (annual, 2025-03-31) — Reconciled Cost Of Revenue: 38700000000.00
DIVISLAB.NS income_statement (quarterly, 2025-03-31) — Reconciled Cost Of Revenue: 9810000000.00
DIVISLAB.NS income_statement (annual, 2025-03-31) — Reconciled Depreciation: 4020000000.00
DIVISLAB.NS income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 1070000000.00
DIVISLAB.NS income_statement (annual, 2025-03-31) — Rent And Landing Fees: 150000000.00
DIVISLAB.NS income_statement (annual, 2025-03-31) — Rent Expense Supplemental: 150000000.00
DIVISLAB.NS income_statement (annual, 2025-03-31) — Research And Development: 270000000.00
DIVISLAB.NS balance_sheet (annual, 2025-03-31) — Restricted Cash: 1880000000.00
DIVISLAB.NS balance_sheet (quarterly, 2025-03-31) — Restricted Cash: 1880000000.00
DIVISLAB.NS balance_sheet (annual, 2025-03-31) — Retained Earnings: 134000000000.00
DIVISLAB.NS balance_sheet (quarterly, 2025-03-31) — Retained Earnings: 134000000000.00
DIVISLAB.NS cash_flow (annual, 2025-03-31) — Sale Of Investment: 35630000000.00
DIVISLAB.NS cash_flow (annual, 2025-03-31) — Sale Of PPE: 0.00
DIVISLAB.NS income_statement (annual, 2025-03-31) — Selling And Marketing Expense: 1360000000.00
DIVISLAB.NS income_statement (annual, 2025-03-31) — Selling General And Administration: 2790000000.00
DIVISLAB.NS balance_sheet (annual, 2025-03-31) — Share Issued: 265468580.00
DIVISLAB.NS balance_sheet (quarterly, 2025-03-31) — Share Issued: 265468580.00
DIVISLAB.NS income_statement (annual, 2025-03-31) — Special Income Charges: -40000000.00
DIVISLAB.NS income_statement (quarterly, 2025-03-31) — Special Income Charges: 0.00
DIVISLAB.NS balance_sheet (annual, 2025-03-31) — Stockholders Equity: 149690000000.00
DIVISLAB.NS balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 149690000000.00
DIVISLAB.NS balance_sheet (annual, 2025-03-31) — Tangible Book Value: 149650000000.00
DIVISLAB.NS balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: 149650000000.00
DIVISLAB.NS income_statement (annual, 2025-03-31) — Tax Effect Of Unusual Items: 2486282.58
DIVISLAB.NS income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: 0.00
DIVISLAB.NS income_statement (annual, 2025-03-31) — Tax Provision: 7250000000.00
DIVISLAB.NS income_statement (quarterly, 2025-03-31) — Tax Provision: 2020000000.00
DIVISLAB.NS income_statement (annual, 2025-03-31) — Tax Rate For Calcs: 0.25
DIVISLAB.NS income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.23
DIVISLAB.NS balance_sheet (annual, 2025-03-31) — Taxes Receivable: 2450000000.00
DIVISLAB.NS balance_sheet (quarterly, 2025-03-31) — Taxes Receivable: 2450000000.00
DIVISLAB.NS cash_flow (annual, 2025-03-31) — Taxes Refund Paid: -8240000000.00
DIVISLAB.NS balance_sheet (annual, 2025-03-31) — Total Assets: 169320000000.00
DIVISLAB.NS balance_sheet (quarterly, 2025-03-31) — Total Assets: 169320000000.00
DIVISLAB.NS balance_sheet (annual, 2025-03-31) — Total Capitalization: 149690000000.00
DIVISLAB.NS balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 149690000000.00
DIVISLAB.NS balance_sheet (annual, 2025-03-31) — Total Debt: 40000000.00
DIVISLAB.NS balance_sheet (quarterly, 2025-03-31) — Total Debt: 40000000.00
DIVISLAB.NS balance_sheet (annual, 2025-03-31) — Total Equity Gross Minority Interest: 149690000000.00
DIVISLAB.NS balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 149690000000.00
DIVISLAB.NS income_statement (annual, 2025-03-31) — Total Expenses: 67540000000.00
DIVISLAB.NS income_statement (quarterly, 2025-03-31) — Total Expenses: 18060000000.00
DIVISLAB.NS balance_sheet (annual, 2025-03-31) — Total Liabilities Net Minority Interest: 19630000000.00
DIVISLAB.NS balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 19630000000.00
DIVISLAB.NS balance_sheet (annual, 2025-03-31) — Total Non Current Assets: 68510000000.00
DIVISLAB.NS balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 68510000000.00
DIVISLAB.NS balance_sheet (annual, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 5110000000.00
DIVISLAB.NS balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 5110000000.00
DIVISLAB.NS income_statement (annual, 2025-03-31) — Total Other Finance Cost: 10000000.00
DIVISLAB.NS balance_sheet (annual, 2025-03-31) — Total Tax Payable: 0.00
DIVISLAB.NS balance_sheet (quarterly, 2025-03-31) — Total Tax Payable: 0.00
DIVISLAB.NS income_statement (annual, 2025-03-31) — Total Unusual Items: 10000000.00
DIVISLAB.NS income_statement (quarterly, 2025-03-31) — Total Unusual Items: 0.00
DIVISLAB.NS income_statement (annual, 2025-03-31) — Total Unusual Items Excluding Goodwill: 10000000.00
DIVISLAB.NS income_statement (quarterly, 2025-03-31) — Total Unusual Items Excluding Goodwill: 0.00
DIVISLAB.NS balance_sheet (annual, 2025-03-31) — Work In Process: 16980000000.00
DIVISLAB.NS balance_sheet (quarterly, 2025-03-31) — Work In Process: 16980000000.00
DIVISLAB.NS balance_sheet (annual, 2025-03-31) — Working Capital: 86290000000.00
DIVISLAB.NS balance_sheet (quarterly, 2025-03-31) — Working Capital: 86290000000.00
DIVISLAB.NS income_statement (quarterly, 2025-06-30) — +Operating Expense: 8370000000.00
DIVISLAB.NS income_statement (quarterly, 2025-06-30) — +Total Revenue: 24100000000.00
DIVISLAB.NS income_statement (quarterly, 2025-06-30) — Basic Average Shares: 265983407.00
DIVISLAB.NS income_statement (quarterly, 2025-06-30) — Basic EPS: 20.49
DIVISLAB.NS income_statement (quarterly, 2025-06-30) — Cost Of Revenue: 9560000000.00
DIVISLAB.NS income_statement (quarterly, 2025-06-30) — Depreciation And Amortization In Income Statement: 1120000000.00
DIVISLAB.NS income_statement (quarterly, 2025-06-30) — Depreciation Income Statement: 1120000000.00
DIVISLAB.NS income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 265983407.00
DIVISLAB.NS income_statement (quarterly, 2025-06-30) — Diluted EPS: 20.49
DIVISLAB.NS income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: 5450000000.00
DIVISLAB.NS income_statement (quarterly, 2025-06-30) — EBIT: 7360000000.00
DIVISLAB.NS income_statement (quarterly, 2025-06-30) — EBITDA: 8480000000.00
DIVISLAB.NS income_statement (quarterly, 2025-06-30) — Gross Profit: 14540000000.00
DIVISLAB.NS income_statement (quarterly, 2025-06-30) — Interest Expense: 30000000.00
DIVISLAB.NS income_statement (quarterly, 2025-06-30) — Interest Expense Non Operating: 30000000.00
DIVISLAB.NS income_statement (quarterly, 2025-06-30) — Minority Interests: 0.00
DIVISLAB.NS income_statement (quarterly, 2025-06-30) — Net Income: 5450000000.00
DIVISLAB.NS income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: 5450000000.00
DIVISLAB.NS income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: 5450000000.00
DIVISLAB.NS income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: 5450000000.00
DIVISLAB.NS income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: 5450000000.00
DIVISLAB.NS income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: 5450000000.00
DIVISLAB.NS income_statement (quarterly, 2025-06-30) — Net Interest Income: -30000000.00
DIVISLAB.NS income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: -30000000.00
DIVISLAB.NS income_statement (quarterly, 2025-06-30) — Normalized EBITDA: 8480000000.00
DIVISLAB.NS income_statement (quarterly, 2025-06-30) — Normalized Income: 5450000000.00
DIVISLAB.NS income_statement (quarterly, 2025-06-30) — Operating Income: 6170000000.00
DIVISLAB.NS income_statement (quarterly, 2025-06-30) — Operating Revenue: 24100000000.00
DIVISLAB.NS income_statement (quarterly, 2025-06-30) — Other Non Operating Income Expenses: 800000000.00
DIVISLAB.NS income_statement (quarterly, 2025-06-30) — Other Operating Expenses: 3850000000.00
DIVISLAB.NS income_statement (quarterly, 2025-06-30) — Otherunder Preferred Stock Dividend: 0.00
DIVISLAB.NS income_statement (quarterly, 2025-06-30) — Pretax Income: 7330000000.00
DIVISLAB.NS income_statement (quarterly, 2025-06-30) — Reconciled Cost Of Revenue: 9560000000.00
DIVISLAB.NS income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 1120000000.00
DIVISLAB.NS income_statement (quarterly, 2025-06-30) — Special Income Charges: 0.00
DIVISLAB.NS income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: 0.00
DIVISLAB.NS income_statement (quarterly, 2025-06-30) — Tax Provision: 1880000000.00
DIVISLAB.NS income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.26
DIVISLAB.NS income_statement (quarterly, 2025-06-30) — Total Expenses: 17930000000.00
DIVISLAB.NS income_statement (quarterly, 2025-06-30) — Total Unusual Items: 0.00
DIVISLAB.NS income_statement (quarterly, 2025-06-30) — Total Unusual Items Excluding Goodwill: 0.00
DIVISLAB.NS income_statement (quarterly, 2025-12-31) — +Operating Expense: 8870000000.00
DIVISLAB.NS income_statement (quarterly, 2025-12-31) — +Total Revenue: 26040000000.00
DIVISLAB.NS income_statement (quarterly, 2025-12-31) — Basic Average Shares: 265241128.00
DIVISLAB.NS income_statement (quarterly, 2025-12-31) — Basic EPS: 21.98
DIVISLAB.NS income_statement (quarterly, 2025-12-31) — Cost Of Revenue: 9450000000.00
DIVISLAB.NS income_statement (quarterly, 2025-12-31) — Depreciation And Amortization In Income Statement: 1180000000.00
DIVISLAB.NS income_statement (quarterly, 2025-12-31) — Depreciation Income Statement: 1180000000.00
DIVISLAB.NS income_statement (quarterly, 2025-12-31) — Diluted Average Shares: 265241128.00
DIVISLAB.NS income_statement (quarterly, 2025-12-31) — Diluted EPS: 21.98
DIVISLAB.NS income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: 5830000000.00
DIVISLAB.NS income_statement (quarterly, 2025-12-31) — EBIT: 7860000000.00
DIVISLAB.NS income_statement (quarterly, 2025-12-31) — EBITDA: 9040000000.00
DIVISLAB.NS income_statement (quarterly, 2025-12-31) — Gross Profit: 16590000000.00
DIVISLAB.NS income_statement (quarterly, 2025-12-31) — Interest Expense: 60000000.00
DIVISLAB.NS income_statement (quarterly, 2025-12-31) — Interest Expense Non Operating: 60000000.00
DIVISLAB.NS income_statement (quarterly, 2025-12-31) — Minority Interests: 0.00
DIVISLAB.NS income_statement (quarterly, 2025-12-31) — Net Income: 5830000000.00
DIVISLAB.NS income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: 5830000000.00
DIVISLAB.NS income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: 5830000000.00
DIVISLAB.NS income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 5830000000.00
DIVISLAB.NS income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 5830000000.00
DIVISLAB.NS income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: 5830000000.00
DIVISLAB.NS income_statement (quarterly, 2025-12-31) — Net Interest Income: -60000000.00
DIVISLAB.NS income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: -60000000.00
DIVISLAB.NS income_statement (quarterly, 2025-12-31) — Normalized EBITDA: 9780000000.00
DIVISLAB.NS income_statement (quarterly, 2025-12-31) — Normalized Income: 6383102564.10
DIVISLAB.NS income_statement (quarterly, 2025-12-31) — Operating Income: 7720000000.00
DIVISLAB.NS income_statement (quarterly, 2025-12-31) — Operating Revenue: 26040000000.00
DIVISLAB.NS income_statement (quarterly, 2025-12-31) — Other Non Operating Income Expenses: 690000000.00
DIVISLAB.NS income_statement (quarterly, 2025-12-31) — Other Operating Expenses: 4020000000.00
DIVISLAB.NS income_statement (quarterly, 2025-12-31) — Otherunder Preferred Stock Dividend: 0.00
DIVISLAB.NS income_statement (quarterly, 2025-12-31) — Pretax Income: 7800000000.00
DIVISLAB.NS income_statement (quarterly, 2025-12-31) — Reconciled Cost Of Revenue: 9450000000.00
DIVISLAB.NS income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 1180000000.00
DIVISLAB.NS income_statement (quarterly, 2025-12-31) — Special Income Charges: -740000000.00
DIVISLAB.NS income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: -186897435.90
DIVISLAB.NS income_statement (quarterly, 2025-12-31) — Tax Provision: 1970000000.00
DIVISLAB.NS income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.25
DIVISLAB.NS income_statement (quarterly, 2025-12-31) — Total Expenses: 18320000000.00
DIVISLAB.NS income_statement (quarterly, 2025-12-31) — Total Unusual Items: -740000000.00
DIVISLAB.NS income_statement (quarterly, 2025-12-31) — Total Unusual Items Excluding Goodwill: -740000000.00
DIVISLAB.NS income_statement (annual, 2026-03-31) — +Operating Expense: 32160000000.00
DIVISLAB.NS income_statement (quarterly, 2026-03-31) — +Operating Expense: 8980000000.00
DIVISLAB.NS income_statement (annual, 2026-03-31) — +Total Revenue: 104760000000.00
DIVISLAB.NS income_statement (quarterly, 2026-03-31) — +Total Revenue: 28310000000.00
DIVISLAB.NS balance_sheet (annual, 2026-03-31) — Accounts Payable: 12110000000.00
DIVISLAB.NS balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 12110000000.00
DIVISLAB.NS balance_sheet (annual, 2026-03-31) — Accounts Receivable: 29840000000.00
DIVISLAB.NS balance_sheet (quarterly, 2026-03-31) — Accounts Receivable: 29840000000.00
DIVISLAB.NS balance_sheet (annual, 2026-03-31) — Accumulated Depreciation: -28550000000.00
DIVISLAB.NS balance_sheet (quarterly, 2026-03-31) — Accumulated Depreciation: -28550000000.00
DIVISLAB.NS balance_sheet (annual, 2026-03-31) — Additional Paid In Capital: 800000000.00
DIVISLAB.NS balance_sheet (quarterly, 2026-03-31) — Additional Paid In Capital: 800000000.00
DIVISLAB.NS balance_sheet (annual, 2026-03-31) — Allowance For Doubtful Accounts Receivable: -90000000.00
DIVISLAB.NS balance_sheet (quarterly, 2026-03-31) — Allowance For Doubtful Accounts Receivable: -90000000.00
DIVISLAB.NS income_statement (annual, 2026-03-31) — Amortization: 20000000.00
DIVISLAB.NS cash_flow (annual, 2026-03-31) — Amortization Cash Flow: 20000000.00
DIVISLAB.NS balance_sheet (annual, 2026-03-31) — Available For Sale Securities: 1360000000.00
DIVISLAB.NS balance_sheet (quarterly, 2026-03-31) — Available For Sale Securities: 1360000000.00
DIVISLAB.NS income_statement (annual, 2026-03-31) — Basic Average Shares: 265468580.00
DIVISLAB.NS income_statement (quarterly, 2026-03-31) — Basic Average Shares: 265277287.00
DIVISLAB.NS income_statement (annual, 2026-03-31) — Basic EPS: 96.75
DIVISLAB.NS income_statement (quarterly, 2026-03-31) — Basic EPS: 28.31
DIVISLAB.NS cash_flow (annual, 2026-03-31) — Beginning Cash Position: 4130000000.00
DIVISLAB.NS cash_flow (annual, 2026-03-31) — Capital Expenditure: -25200000000.00
DIVISLAB.NS balance_sheet (annual, 2026-03-31) — Capital Lease Obligations: 70000000.00
DIVISLAB.NS balance_sheet (quarterly, 2026-03-31) — Capital Lease Obligations: 70000000.00
DIVISLAB.NS balance_sheet (annual, 2026-03-31) — Capital Stock: 530000000.00
DIVISLAB.NS balance_sheet (quarterly, 2026-03-31) — Capital Stock: 530000000.00
DIVISLAB.NS balance_sheet (annual, 2026-03-31) — Cash And Cash Equivalents: 1280000000.00
DIVISLAB.NS balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 1280000000.00
DIVISLAB.NS balance_sheet (annual, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 32360000000.00
DIVISLAB.NS balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 32360000000.00
DIVISLAB.NS cash_flow (annual, 2026-03-31) — Cash Dividends Paid: -7970000000.00
DIVISLAB.NS balance_sheet (annual, 2026-03-31) — Cash Equivalents: 810000000.00
DIVISLAB.NS balance_sheet (quarterly, 2026-03-31) — Cash Equivalents: 810000000.00
DIVISLAB.NS balance_sheet (annual, 2026-03-31) — Cash Financial: 470000000.00
DIVISLAB.NS balance_sheet (quarterly, 2026-03-31) — Cash Financial: 470000000.00
DIVISLAB.NS cash_flow (annual, 2026-03-31) — Change In Inventory: -7180000000.00
DIVISLAB.NS cash_flow (annual, 2026-03-31) — Change In Other Current Assets: -3480000000.00
DIVISLAB.NS cash_flow (annual, 2026-03-31) — Change In Other Current Liabilities: 9170000000.00
DIVISLAB.NS cash_flow (annual, 2026-03-31) — Change In Payable: 2940000000.00
DIVISLAB.NS cash_flow (annual, 2026-03-31) — Change In Receivables: -1410000000.00
DIVISLAB.NS cash_flow (annual, 2026-03-31) — Change In Working Capital: 990000000.00
DIVISLAB.NS cash_flow (annual, 2026-03-31) — Changes In Cash: -2850000000.00
DIVISLAB.NS balance_sheet (annual, 2026-03-31) — Common Stock: 530000000.00
DIVISLAB.NS balance_sheet (quarterly, 2026-03-31) — Common Stock: 530000000.00
DIVISLAB.NS balance_sheet (annual, 2026-03-31) — Common Stock Equity: 167610000000.00
DIVISLAB.NS balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 167610000000.00
DIVISLAB.NS balance_sheet (annual, 2026-03-31) — Construction In Progress: 22470000000.00
DIVISLAB.NS balance_sheet (quarterly, 2026-03-31) — Construction In Progress: 22470000000.00
DIVISLAB.NS income_statement (annual, 2026-03-31) — Cost Of Revenue: 42810000000.00
DIVISLAB.NS income_statement (quarterly, 2026-03-31) — Cost Of Revenue: 11190000000.00
DIVISLAB.NS balance_sheet (annual, 2026-03-31) — Current Assets: 110960000000.00
DIVISLAB.NS balance_sheet (quarterly, 2026-03-31) — Current Assets: 110960000000.00
DIVISLAB.NS balance_sheet (annual, 2026-03-31) — Current Capital Lease Obligation: 20000000.00
DIVISLAB.NS balance_sheet (quarterly, 2026-03-31) — Current Capital Lease Obligation: 20000000.00
DIVISLAB.NS balance_sheet (annual, 2026-03-31) — Current Debt: 0.00
DIVISLAB.NS balance_sheet (quarterly, 2026-03-31) — Current Debt: 0.00
DIVISLAB.NS balance_sheet (annual, 2026-03-31) — Current Debt And Capital Lease Obligation: 20000000.00
DIVISLAB.NS balance_sheet (quarterly, 2026-03-31) — Current Debt And Capital Lease Obligation: 20000000.00
DIVISLAB.NS balance_sheet (annual, 2026-03-31) — Current Liabilities: 20430000000.00
DIVISLAB.NS balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 20430000000.00
DIVISLAB.NS cash_flow (annual, 2026-03-31) — Depreciation: 4610000000.00
DIVISLAB.NS cash_flow (annual, 2026-03-31) — Depreciation And Amortization: 4630000000.00
DIVISLAB.NS income_statement (annual, 2026-03-31) — Depreciation And Amortization In Income Statement: 4630000000.00
DIVISLAB.NS income_statement (quarterly, 2026-03-31) — Depreciation And Amortization In Income Statement: 1200000000.00
DIVISLAB.NS income_statement (annual, 2026-03-31) — Depreciation Income Statement: 4610000000.00
DIVISLAB.NS income_statement (quarterly, 2026-03-31) — Depreciation Income Statement: 1200000000.00
DIVISLAB.NS income_statement (annual, 2026-03-31) — Diluted Average Shares: 265468580.00
DIVISLAB.NS income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 265277287.00
DIVISLAB.NS income_statement (annual, 2026-03-31) — Diluted EPS: 96.75
DIVISLAB.NS income_statement (quarterly, 2026-03-31) — Diluted EPS: 28.31
DIVISLAB.NS income_statement (annual, 2026-03-31) — Diluted NI Availto Com Stockholders: 25680000000.00
DIVISLAB.NS income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: 7510000000.00
DIVISLAB.NS balance_sheet (annual, 2026-03-31) — Dividends Payable: 10000000.00
DIVISLAB.NS balance_sheet (quarterly, 2026-03-31) — Dividends Payable: 10000000.00
DIVISLAB.NS income_statement (annual, 2026-03-31) — EBIT: 34110000000.00
DIVISLAB.NS income_statement (quarterly, 2026-03-31) — EBIT: 9690000000.00
DIVISLAB.NS income_statement (annual, 2026-03-31) — EBITDA: 38740000000.00
DIVISLAB.NS income_statement (quarterly, 2026-03-31) — EBITDA: 10890000000.00
DIVISLAB.NS cash_flow (annual, 2026-03-31) — End Cash Position: 1280000000.00
DIVISLAB.NS balance_sheet (annual, 2026-03-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 690000000.00
DIVISLAB.NS balance_sheet (quarterly, 2026-03-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 690000000.00
DIVISLAB.NS cash_flow (annual, 2026-03-31) — Financing Cash Flow: -8040000000.00
DIVISLAB.NS balance_sheet (annual, 2026-03-31) — Finished Goods: 3490000000.00
DIVISLAB.NS balance_sheet (quarterly, 2026-03-31) — Finished Goods: 3490000000.00
DIVISLAB.NS cash_flow (annual, 2026-03-31) — Free Cash Flow: 2180000000.00
DIVISLAB.NS cash_flow (annual, 2026-03-31) — Gain Loss On Investment Securities: -40000000.00
DIVISLAB.NS cash_flow (annual, 2026-03-31) — Gain Loss On Sale Of PPE: 0.00
DIVISLAB.NS income_statement (annual, 2026-03-31) — General And Administrative Expense: 1710000000.00
DIVISLAB.NS balance_sheet (annual, 2026-03-31) — Goodwill And Other Intangible Assets: 60000000.00
DIVISLAB.NS balance_sheet (quarterly, 2026-03-31) — Goodwill And Other Intangible Assets: 60000000.00
DIVISLAB.NS balance_sheet (annual, 2026-03-31) — Gross Accounts Receivable: 29930000000.00
DIVISLAB.NS balance_sheet (quarterly, 2026-03-31) — Gross Accounts Receivable: 29930000000.00
DIVISLAB.NS balance_sheet (annual, 2026-03-31) — Gross PPE: 116240000000.00
DIVISLAB.NS balance_sheet (quarterly, 2026-03-31) — Gross PPE: 116240000000.00
DIVISLAB.NS income_statement (annual, 2026-03-31) — Gross Profit: 61950000000.00
DIVISLAB.NS income_statement (quarterly, 2026-03-31) — Gross Profit: 17120000000.00
DIVISLAB.NS balance_sheet (annual, 2026-03-31) — Hedging Assets Current: 10000000.00
DIVISLAB.NS balance_sheet (quarterly, 2026-03-31) — Hedging Assets Current: 10000000.00
DIVISLAB.NS income_statement (annual, 2026-03-31) — Interest Expense: 230000000.00
DIVISLAB.NS income_statement (quarterly, 2026-03-31) — Interest Expense: 60000000.00
DIVISLAB.NS income_statement (annual, 2026-03-31) — Interest Expense Non Operating: 230000000.00
DIVISLAB.NS income_statement (quarterly, 2026-03-31) — Interest Expense Non Operating: 60000000.00
DIVISLAB.NS income_statement (annual, 2026-03-31) — Interest Income: 2840000000.00
DIVISLAB.NS income_statement (annual, 2026-03-31) — Interest Income Non Operating: 2840000000.00
DIVISLAB.NS cash_flow (annual, 2026-03-31) — Interest Paid Cff: -50000000.00
DIVISLAB.NS cash_flow (annual, 2026-03-31) — Interest Received Cfi: 2840000000.00
DIVISLAB.NS balance_sheet (annual, 2026-03-31) — Inventory: 39540000000.00
DIVISLAB.NS balance_sheet (quarterly, 2026-03-31) — Inventory: 39540000000.00
DIVISLAB.NS balance_sheet (annual, 2026-03-31) — Invested Capital: 167610000000.00
DIVISLAB.NS balance_sheet (quarterly, 2026-03-31) — Invested Capital: 167610000000.00
DIVISLAB.NS cash_flow (annual, 2026-03-31) — Investing Cash Flow: -22190000000.00
DIVISLAB.NS balance_sheet (annual, 2026-03-31) — Investmentin Financial Assets: 690000000.00
DIVISLAB.NS balance_sheet (quarterly, 2026-03-31) — Investmentin Financial Assets: 690000000.00
DIVISLAB.NS balance_sheet (annual, 2026-03-31) — Land And Improvements: 27340000000.00
DIVISLAB.NS balance_sheet (quarterly, 2026-03-31) — Land And Improvements: 27340000000.00
DIVISLAB.NS balance_sheet (annual, 2026-03-31) — Long Term Capital Lease Obligation: 50000000.00
DIVISLAB.NS balance_sheet (quarterly, 2026-03-31) — Long Term Capital Lease Obligation: 50000000.00
DIVISLAB.NS balance_sheet (annual, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 50000000.00
DIVISLAB.NS balance_sheet (quarterly, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 50000000.00
DIVISLAB.NS balance_sheet (annual, 2026-03-31) — Long Term Provisions: 810000000.00
DIVISLAB.NS balance_sheet (quarterly, 2026-03-31) — Long Term Provisions: 810000000.00
DIVISLAB.NS balance_sheet (annual, 2026-03-31) — Machinery Furniture Equipment: 61800000000.00
DIVISLAB.NS balance_sheet (quarterly, 2026-03-31) — Machinery Furniture Equipment: 61800000000.00
DIVISLAB.NS income_statement (annual, 2026-03-31) — Minority Interests: 0.00
DIVISLAB.NS income_statement (quarterly, 2026-03-31) — Minority Interests: 0.00
DIVISLAB.NS cash_flow (annual, 2026-03-31) — Net Foreign Currency Exchange Gain Loss: -860000000.00
DIVISLAB.NS income_statement (annual, 2026-03-31) — Net Income: 25680000000.00
DIVISLAB.NS income_statement (quarterly, 2026-03-31) — Net Income: 7510000000.00
DIVISLAB.NS income_statement (annual, 2026-03-31) — Net Income Common Stockholders: 25680000000.00
DIVISLAB.NS income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: 7510000000.00
DIVISLAB.NS income_statement (annual, 2026-03-31) — Net Income Continuous Operations: 25680000000.00
DIVISLAB.NS income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: 7510000000.00
DIVISLAB.NS income_statement (annual, 2026-03-31) — Net Income From Continuing And Discontinued Operation: 25680000000.00
DIVISLAB.NS income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: 7510000000.00
DIVISLAB.NS income_statement (annual, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: 25680000000.00
DIVISLAB.NS income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: 7510000000.00
DIVISLAB.NS cash_flow (annual, 2026-03-31) — Net Income From Continuing Operations: 33880000000.00
DIVISLAB.NS income_statement (annual, 2026-03-31) — Net Income Including Noncontrolling Interests: 25680000000.00
DIVISLAB.NS income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: 7510000000.00
DIVISLAB.NS income_statement (annual, 2026-03-31) — Net Interest Income: 2600000000.00
DIVISLAB.NS income_statement (quarterly, 2026-03-31) — Net Interest Income: -60000000.00
DIVISLAB.NS cash_flow (annual, 2026-03-31) — Net Investment Purchase And Sale: 140000000.00
DIVISLAB.NS income_statement (annual, 2026-03-31) — Net Non Operating Interest Income Expense: 2600000000.00
DIVISLAB.NS income_statement (quarterly, 2026-03-31) — Net Non Operating Interest Income Expense: -60000000.00
DIVISLAB.NS balance_sheet (annual, 2026-03-31) — Net PPE: 87690000000.00
DIVISLAB.NS balance_sheet (quarterly, 2026-03-31) — Net PPE: 87690000000.00
DIVISLAB.NS cash_flow (annual, 2026-03-31) — Net PPE Purchase And Sale: -25170000000.00
DIVISLAB.NS balance_sheet (annual, 2026-03-31) — Net Tangible Assets: 167550000000.00
DIVISLAB.NS balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: 167550000000.00
DIVISLAB.NS balance_sheet (annual, 2026-03-31) — Non Current Deferred Revenue: 2180000000.00
DIVISLAB.NS balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Revenue: 2180000000.00
DIVISLAB.NS balance_sheet (annual, 2026-03-31) — Non Current Deferred Taxes Assets: 140000000.00
DIVISLAB.NS balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Taxes Assets: 140000000.00
DIVISLAB.NS balance_sheet (annual, 2026-03-31) — Non Current Deferred Taxes Liabilities: 4690000000.00
DIVISLAB.NS balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Taxes Liabilities: 4690000000.00
DIVISLAB.NS balance_sheet (annual, 2026-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 810000000.00
DIVISLAB.NS balance_sheet (quarterly, 2026-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 810000000.00
DIVISLAB.NS balance_sheet (annual, 2026-03-31) — Non Current Prepaid Assets: 790000000.00
DIVISLAB.NS balance_sheet (quarterly, 2026-03-31) — Non Current Prepaid Assets: 790000000.00
DIVISLAB.NS income_statement (annual, 2026-03-31) — Normalized EBITDA: 39440000000.00
DIVISLAB.NS income_statement (quarterly, 2026-03-31) — Normalized EBITDA: 10890000000.00
DIVISLAB.NS income_statement (annual, 2026-03-31) — Normalized Income: 26210578512.40
DIVISLAB.NS income_statement (quarterly, 2026-03-31) — Normalized Income: 7510000000.00
DIVISLAB.NS cash_flow (annual, 2026-03-31) — Operating Cash Flow: 27380000000.00
DIVISLAB.NS income_statement (annual, 2026-03-31) — Operating Income: 29790000000.00
DIVISLAB.NS income_statement (quarterly, 2026-03-31) — Operating Income: 8140000000.00
DIVISLAB.NS income_statement (annual, 2026-03-31) — Operating Revenue: 104760000000.00
DIVISLAB.NS income_statement (quarterly, 2026-03-31) — Operating Revenue: 28310000000.00
DIVISLAB.NS balance_sheet (annual, 2026-03-31) — Ordinary Shares Number: 265468580.00
DIVISLAB.NS balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 265468580.00
DIVISLAB.NS balance_sheet (annual, 2026-03-31) — Other Current Assets: 1140000000.00
DIVISLAB.NS balance_sheet (quarterly, 2026-03-31) — Other Current Assets: 1140000000.00
DIVISLAB.NS balance_sheet (annual, 2026-03-31) — Other Current Liabilities: 120000000.00
DIVISLAB.NS balance_sheet (quarterly, 2026-03-31) — Other Current Liabilities: 120000000.00
DIVISLAB.NS balance_sheet (annual, 2026-03-31) — Other Equity Interest: 167080000000.00
DIVISLAB.NS balance_sheet (quarterly, 2026-03-31) — Other Equity Interest: 167080000000.00
DIVISLAB.NS balance_sheet (annual, 2026-03-31) — Other Intangible Assets: 60000000.00
DIVISLAB.NS balance_sheet (quarterly, 2026-03-31) — Other Intangible Assets: 60000000.00
DIVISLAB.NS balance_sheet (annual, 2026-03-31) — Other Inventories: 150000000.00
DIVISLAB.NS balance_sheet (quarterly, 2026-03-31) — Other Inventories: 150000000.00
DIVISLAB.NS cash_flow (annual, 2026-03-31) — Other Non Cash Items: -2610000000.00
DIVISLAB.NS balance_sheet (annual, 2026-03-31) — Other Non Current Assets: 1430000000.00
DIVISLAB.NS balance_sheet (quarterly, 2026-03-31) — Other Non Current Assets: 1430000000.00